Business Details
30 Years
experience
Your Trusted Partner for Consumer Healthcare Consulting Solutions
Founded in 1996 by Jeremy Kelly and Jason Kalik, Evidence Based Marketing (EBM) (EBM) is a specialist Consumer Healthcare (CHC) consulting and advisory practice. Our founders bring over 30 years of combined industry experience from senior roles at global corporations such as GlaxoSmithKline, Pfizer, and Novartis. We have delivered strategic insights to more than 50 multinational and local CHC companies across diverse markets including North America, China, and Europe. Our proprietary Evidence Base platform offers systematic analytical tools to enhance data-driven decision-making for global clients. We specialise in brand acquisition, portfolio analysis, due diligence, and strategic planning across key CHC categories.Our expertise extends to leveraging major data sources like IQVIA and Nielsen to optimise business outcomes. Through partnerships such as China Deal Flow with TPP Healthcare, we provide tailored solutions for market entry and growth in high-potential regions. Our commitment to innovation and client-centric approaches has established us as trusted advisors in the CHC sector. We prioritise transparency, delivering actionable insights that align with stakeholders' strategic objectives. With a global network and deep sector knowledge, we empower clients to navigate complex healthcare markets effectively.
Services
Consulting
Strategic Planning
M&A Advisory
Data Analytics
Market Expansion
Details
- Year established: 1996
Highlights and features
- We offer 30+ years of combined experience in Consumer Healthcare consulting.
- Our team has worked with global CHC leaders like GlaxoSmithKline and Pfizer.
- We deploy proprietary tools like Evidence Base for advanced analytics.
- We provide tailored solutions for market entry in high-growth regions like China.
- Our global network spans 50+ companies across diverse healthcare categories.
Services
Consulting
Our consulting services provide strategic guidance to Consumer Healthcare companies, leveraging 30+ years of industry expertise. We deliver tailored solutions for market analysis, portfolio optimisation, and business development. Our approach combines global best practices with local market insights to drive sustainable growth.
M&A Advisory
We specialise in mergers and acquisitions advisory for CHC firms, offering target identification, due diligence, and valuation services. Our global network ensures access to high-potential opportunities in emerging and established markets, enhancing portfolio diversification.
Data Analytics
Our Evidence Base platform transforms raw data into actionable insights, enabling faster, informed decisions. By integrating tools like IQVIA and Nielsen, we help clients maximise ROI from existing data investments across global operations.
Market Expansion
We support CHC companies in entering new markets through strategic planning and local partnerships. Our China Deal Flow initiative, in collaboration with TPP Healthcare, offers bespoke solutions for navigating regulatory and commercial challenges in Asia.
Strategic Planning
Our strategic planning services focus on long-term business development, including portfolio analysis and geographic expansion. We align client objectives with market trends to create robust, data-driven strategies that ensure competitive advantage in dynamic healthcare environments.
People
Jeremy Kelly
Co-Founder & Director
Jeremy co-founded EBM with 15+ years in CHC leadership roles at GlaxoSmithKline and Pfizer. He specialises in strategic market expansion and data-driven decision-making for global clients.
Jason Kalik
Co-Founder & Director
Jason brings 15+ years of CHC experience from senior roles at Novartis and J&J. He focuses on business development and analytical tools to enhance client decision-making across international markets.
Questions
What services does Evidence Based Marketing (EBM) (EBM) (EBM) offer?
EBM provides consulting in M&A advisory, strategic planning, data analytics, and market expansion for Consumer Healthcare companies globally.
How does EBM support businesses entering the Chinese market?
Through China Deal Flow, we offer tailored advice on market entry, partner selection, and regulatory strategies in China's CHC sector.
What is Evidence Base™?
Evidence Base™ is our proprietary analytical platform that optimises data-driven decision-making for healthcare clients worldwide.
Which regions does EBM operate in?
We work across North America, China, Latin America, the Middle East, Africa, and Europe.
